Literature DB >> 12901301

Cell adhesion onto highly curved surfaces: one-step immobilization of human erythrocyte membranes on silica beads.

Stefan Kaufmann1, Motomu Tanaka.   

Abstract

This paper deals with single-step, orientation-selective immobilization of human erythrocyte membranes on bare silica beads with different topographies: 1) solid (nonporous) silica beads with a diameter of 3 microns and 2) porous silica beads with a diameter of 5 microns. Erythrocyte membranes were immobilized onto beads simply by incubation, without sonication or osmotic lysis. Membrane orientation before and after immobilization was identified with two immunofluorescence labels: 1) the extracellular part of glycophorin can be labeled with a first monoclonal antibody and a second polyclonal antibody with fluorescence dyes (outside label), while 2) the cytoplasmic domain of Band 3 can be recognized with a first monoclonal antibody and a second fluorescent polyclonal antibody (inside label). Adherent erythrocytes on the beads all ruptured, inverted the asymmetric orientation of the membrane, and selectively exposed their cytoplasmic domain. The surface topography did not influence the orientation or the amount of immobilized membrane. On the other hand, the fact that no adsorption or rupture of erythrocytes could be observed on planar quartz substrates suggests a significant influence of contact curvature on adhesion energy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901301     DOI: 10.1002/cphc.200200537

Source DB:  PubMed          Journal:  Chemphyschem        ISSN: 1439-4235            Impact factor:   3.102


  7 in total

1.  Giant unilamellar vesicles electroformed from native membranes and organic lipid mixtures under physiological conditions.

Authors:  L-Ruth Montes; Alicia Alonso; Felix M Goñi; Luis A Bagatolli
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

2.  Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity.

Authors:  Stephen C Rogers; Jerlinda G C Ross; Andre d'Avignon; Lindsey B Gibbons; Vered Gazit; Mojibade N Hassan; Dylan McLaughlin; Sherraine Griffin; Tara Neumayr; Malcolm Debaun; Michael R DeBaun; Allan Doctor
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

Review 3.  Biomimetic particles as therapeutics.

Authors:  Randall A Meyer; Joel C Sunshine; Jordan J Green
Journal:  Trends Biotechnol       Date:  2015-08-12       Impact factor: 19.536

4.  Quantifying dynamic range in red blood cell energetics: Evidence of progressive energy failure during storage.

Authors:  Stephen C Rogers; Xia Ge; Mary Brummet; Xue Lin; David D Timm; Andre d'Avignon; Joel R Garbow; Jeff Kao; Jaya Prakash; Aaron Issaian; Elan Z Eisenmesser; Julie A Reisz; Angelo D'Alessandro; Allan Doctor
Journal:  Transfusion       Date:  2021-04-08       Impact factor: 3.157

5.  Obtaining control of cell surface functionalizations via Pre-targeting and Supramolecular host guest interactions.

Authors:  Mark T M Rood; Silvia J Spa; Mick M Welling; Jan Bart Ten Hove; Danny M van Willigen; Tessa Buckle; Aldrik H Velders; Fijs W B van Leeuwen
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

6.  Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.

Authors:  Kaiqi Sun; Angelo D'Alessandro; Mostafa H Ahmed; Yujin Zhang; Anren Song; Tzu-Ping Ko; Travis Nemkov; Julie A Reisz; Hongyu Wu; Morayo Adebiyi; Zhangzhe Peng; Jing Gong; Hong Liu; Aji Huang; Yuan Edward Wen; Alexander Q Wen; Vladimir Berka; Mikhail V Bogdanov; Osheiza Abdulmalik; Leng Han; Ah-Lim Tsai; Modupe Idowu; Harinder S Juneja; Rodney E Kellems; William Dowhan; Kirk C Hansen; Martin K Safo; Yang Xia
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

Review 7.  Biomimetic silica microspheres in biosensing.

Authors:  Sireesha Chemburu; Kyle Fenton; Gabriel P Lopez; Reema Zeineldin
Journal:  Molecules       Date:  2010-03-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.